GE HealthCare stock drops 7.3% after missing Q1 earnings and cutting guidance

6 articles · Updated · Barron's · Apr 29

GE HealthCare reported Q1 adjusted earnings per share of 99 cents on $5.1 billion sales, below Wall Street expectations, and lowered its 2026 EPS outlook to $4.80–$5.00.
Operating margins also missed estimates, and the company cited inflation and higher chip, oil, and freight costs for the reduced profit outlook, with shares falling sharply in premarket trading.
While GE HealthCare maintains a record $22 billion backlog, it lags behind GE Aerospace and GE Vernova, both of which have outperformed since the GE split amid stronger demand in their sectors.

Revenue is up but profits are down. Is GE HealthCare's stock a warning sign or a major buying opportunity?

While Wall Street frets over profits, is AI leadership GE HealthCare's real competitive edge for the future?

With AI driving chip shortages, can GE HealthCare innovate its way out of this supply chain crisis?

Are new FDA and EU regulations a bigger threat to GE HealthCare than its current supply chain woes?

As new tariffs and global tensions hike costs, can MedTech giants avoid passing the bill onto hospitals?

Is inflation the real problem, or is it an over-reliance on a fragile and concentrated global supply chain?